Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • Nora AI
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

Scanfil Q2'23: Record result & neutral valuation

Scanfil

Scanfil’s generated a record result in line with our expectations in Q2 and reiterated its outlook. We only made marginal but positive estimate changes for the coming years after the report. We feel the short-term valuation of the share is neutral, although in the longer term, Scanfil still offers a strong, profitable growth investment story. Analyst Antti Viljakainen comments on second quarter highlights and outlook.

Our latest research on Scanfil: https://www.inderes.se/research/scanfil-price-and-value-seem-to-have-found-harmony

Timings:
00:00 Start
00:19 Scanfil Q2’23
01:45 Segments in Q2
02:36 Change of CEO
04:02 Inventory levels
05:20 Expectations
07:49 Valuation

Stay up to date
Analyst Interviews

Recent videos

Truecaller, Webcast, Press Conference, 2025
15.12.2025, 13.00 Truecaller
Herantis Pharma as an Investment | Life Science Night Dec 9, 2025
15.12.2025, 13.00 Herantis Pharma
Flügger – Præsentation af regnskabet for 1. halvår 2025/26
15.12.2025, 11.00 Flügger Group
HCA Morgenbørs 15/12 - Futures rebounder efter negativ stemning fredag
15.12.2025, 09.18 A.P. Møller - Mærsk
Orion as an Investment | Life Science Night Dec. 9, 2025
13.12.2025, 12.50 Orion
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.